BD acquires infusion pump startup; medical marijuana company signs deal to develop vaporizer;

> Fresh off the acquisition of infusion pump maker CareFusion ($CFN), Becton Dickinson ($BDX) purchased startup Crisi Medical Systems for an undisclosed sum. The new addition is expected to integrate data routinely available with preset intravenous infusion pumps to manual IV delivery, which includes anesthesia as well as emergency applications. Story

> Australia's medical marijuana company Phytotech Medical announced it has entered into an agreement with Israel's Canigma A.L. to develop a revolutionary capsule-based vaporizer to administer medical cannabis. Release

> Texas' Neos Therapeutics received $20.6 million to fund late-stage regulatory work on extended-release formulations of a crops of ADHD drugs that are now facing or being prepared for regulatory review. Story

Suggested Articles

J&J figures its partner Genmab owes a share of Darzalex Faspro royalties to Halozyme for its subcutaneous delivery tech. Genmab doesn't agree.

Bexson Biomedical and Stevanato Group teamed up to develop a ketamine pump that may help patients better manage pain at home.

Australia's University of New South Wales and Uka Tarsadia University in India will join forces to explore contact lenses for ocular drug delivery.